TNF and Parkinson disease: Our reliance on genetic and transcriptomic data alone does not capture post-transcriptional regulation or protein-level effects, or the influence of clinical factors such as medication use (e.g., levodopa or dopaminergic agonists), which may modulate TNF pathway activity in PD.